UNI-EN 81:Current report 81 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 81 | / | 2013 | | ||||||
| Date of issue: | 2013-06-20 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 81 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time of the settlement Operation Number of shares Unit price (BGN) 10.06.2013 Sale 1000 3.07 10.06.2013 Sale 2000 3.07 10.06.2013 Sale 1000 3.07 10.06.2013 Sale 150 3.07 10.06.2013 Sale 50000 3.05 10.06.2013 Sale 1900 3.05 10.06.2013 Sale 3000 3.07 10.06.2013 Sale 350 3.07 10.06.2013 Sale 3100 3.05 11.06.2013 Sale 1500 3.05 11.06.2013 Sale 19 3.065 11.06.2013 Sale 500 3.05 11.06.2013 Sale 1000 3.05 11.06.2013 Sale 2000 3.05 11.06.2013 Sale 2000 3.05 11.06.2013 Sale 2000 3.05 11.06.2013 Sale 2000 3.05 11.06.2013 Sale 2000 3.05 11.06.2013 Sale 1000 3.05 11.06.2013 Sale 40 3.07 11.06.2013 Sale 340 3.07 11.06.2013 Sale 1500 3.075 11.06.2013 Sale 50000 3.065 11.06.2013 Sale 6000 3.08 11.06.2013 Sale 300 3.09 11.06.2013 Sale 300 3.08 11.06.2013 Sale 500 3.093 11.06.2013 Sale 800 3.05 11.06.2013 Sale 2000 3.05 11.06.2013 Sale 1000 3.05 11.06.2013 Sale 2000 3.05 11.06.2013 Sale 1000 3.05 11.06.2013 Sale 2000 3.05 11.06.2013 Sale 1000 3.05 11.06.2013 Sale 4000 3.05 11.06.2013 Sale 981 3.065 11.06.2013 Sale 660 3.07 11.06.2013 Sale 1000 3.07 11.06.2013 Sale 660 3.07 11.06.2013 Sale 2160 3.08 11.06.2013 Sale 100 3.08 11.06.2013 Sale 1100 3.08 11.06.2013 Sale 640 3.08 11.06.2013 Sale 200 3.09 11.06.2013 Sale 100 3.09 11.06.2013 Sale 600 3.09 11.06.2013 Sale 500 3.09 11.06.2013 Sale 300 3.09 12.06.2013 Sale 400 3.089 12.06.2013 Sale 310 3.099 12.06.2013 Sale 1000 3.09 12.06.2013 Sale 300 3.09 12.06.2013 Sale 500 3.09 12.06.2013 Sale 100 3.093 12.06.2013 Sale 600 3.086 12.06.2013 Sale 600 3.086 12.06.2013 Sale 705 3.09 12.06.2013 Sale 4500 3.093 12.06.2013 Sale 1310 3.099 12.06.2013 Sale 302 3.085 12.06.2013 Sale 398 3.085 12.06.2013 Sale 100 3.093 12.06.2013 Sale 600 3.093 12.06.2013 Sale 600 3.086 12.06.2013 Sale 295 3.09 12.06.2013 Sale 300 3.093 12.06.2013 Sale 200 3.093 12.06.2013 Sale 690 3.099 12.06.2013 Sale 690 3.099 13.06.2013 Sale 300 3.102 13.06.2013 Sale 500 3.11 13.06.2013 Sale 50 3.102 13.06.2013 Sale 450 3.102 14.06.2013 Sale 254 3.11 14.06.2013 Sale 2000 3.11 14.06.2013 Sale 100 3.11 14.06.2013 Sale 1700 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 2000 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 150 3.1 14.06.2013 Sale 150 3.1 14.06.2013 Sale 2000 3.1 14.06.2013 Sale 2000 3.11 14.06.2013 Sale 300 3.101 14.06.2013 Sale 246 3.11 14.06.2013 Sale 500 3.11 14.06.2013 Sale 100 3.11 14.06.2013 Sale 500 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 2500 3.1 14.06.2013 Sale 300 3.11 14.06.2013 Sale 105871 3.1 14.06.2013 Sale 500 3.1 14.06.2013 Sale 278 3.101 14.06.2013 Sale 1000 3.1 14.06.2013 Sale 1000 3.1 14.06.2013 Sale 100 3.1 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. Legal grounds: Art.160.4 of the Act on Trading in Financial Instruments of 29 July 2005. Signatures of individuals authorized to represent the Company: Ognian Donev | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 81 re insiders transactions.doc Current report 81 re insiders transactions.doc | Current report 81 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-06-20 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
